Global Infectious Disease Diagnostics Testing Market 2015-2019

LONDON, Oct. 21, 2015 /PRNewswire/ -- About infectious disease diagnostic

Infectious diseases are disorders caused by micro-organisms such as viruses, bacteria, fungi, and parasites. These diseases can be transmitted from one individual to another through either direct contact or indirect contact. Anti-infective drugs are used to kill (cidal) or stop the growth (static) of infectious agents. Based on the target organism, anti-infective drugs can be categorized into antibacterial, antiviral, antifungal, and antiparasitic. Anti-infective drugs can act via host defense system or can directly target the causative agent. Infectious diseases such as bacterial infections, respiratory diseases, HPV, and HIV are gradually increasing worldwide. For instance, based on the study of WHO global health observatory (GHO) data, it is estimated that in 2013 34-38 million people suffered from HIV infection worldwide. Infectious diseases increasingly threaten public health and contribute significantly to the rising costs of health care. Infectious disease diagnostic tests help in detecting new pathogens and specific pathogens, monitoring response to therapy, assessing prognosis, and determining appropriate treatment.

Technavio's analysts forecast the global infectious disease diagnostic testing market to grow at a CAGR of 11.48% over the period 2014-2019.

Covered in this report

The report covers the present scenario and growth prospects of the global infectious disease diagnostic testing market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of following product categories:

Molecular diagnostic test
POC infectious disease diagnostics test
POC infectious disease diagnostics test is classified into the following based on application:

Respiratory
HIV
HAIs
Sexual health
Tropical diseases
Liver
Technavio's report, Global Infectious Disease Diagnostic Testing Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers APAC, Europe, Latin America, MEA, and North America; it also covers the landscape of the global infectious disease diagnostic testing market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market

Key regions

Americas
APAC
EMEA
Key vendors

Abbott Diagnostic
Alere
bioMérieux
Diasorin
Roche Diagnostic
Other prominent vendors

Beckman Coulter
Becton, Dickinson and Company (BD)
Bio-Rad Laboratories
Cavidi
Cepheid
Corgenix
Diaxonhit
Eiken Chemical
EMD Millipore
Epitope Diagnostic
EUROIMMUN
Gold Standard Diagnostics
Hologic
Immunetics
InBios International
J.Mitra
Meridian Bioscience
OraSure Technologies
ORGENTEC Diagnostika
Ortho Clinical Diagnostics
QIAGEN
Quidel
Siemens Healthcare Diagnostics
TECHLAB
Thermo Fisher Scientific
Trinity Biotech
Key market driver

Increase in prevalence of infectious diseases
For a full, detailed list, view our report
Key market challenge

Emerging infectious diseases
For a full, detailed list, view our report
Key market trend

Advances in technology
For a full, detailed list, view our report
Key questions answered in this report

What will the market size be in 2019 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Download the full report: https://www.reportbuyer.com/product/3334952/

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]  
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer

Related Links

http://www.reportbuyer.com